ARCHIVES

Phase III Vaccine Trial Fails To Improve Overall Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Starts “Exceptional Responders” Study

September 26, 2014

ODACSupports Temodal For Treatment of Astrocytoma

January 22, 1999

Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development

March 15, 1991

In Brief: Roper To Resign From CDC; Clinton Nominates Phillip Lee For Asst. Secretary For Health

March 19, 1993

DC Board Okay One Recompetition, Disapproves Two

November 12, 1982

Funding Opportunities: Aging Institute Offers Program Announcement

February 6, 1998